
Indian companies to supply US API
India-based Arch Pharmalabs has entered into a strategic partnership with Orochem Technologies, to manufacture a US company?s active pharmaceutical ingredient (API) in late-stage clinical development using simulated moving bed (SMB) chromatography.
India-based Arch Pharmalabs has entered into a strategic partnership with Orochem Technologies, to manufacture a US company’s active pharmaceutical ingredient (API) in late-stage clinical development using simulated moving bed (SMB) chromatography.
Arch Pharmalabs provides small molecule process R&D and full life-cycle custom synthesis and manufacturing services, while Orochem Technologies manufactures SMB equipment and stationary chromatography phases for bioanalytical, solid-phase extraction, flash and preparative applications. The collaboration marks the first time that plant-scale SMB has been used to manufacture an API in India.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.





